Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FENFLURAMINE-PHENTERMINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 48 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Poston, WSC; Haddock, CK; Dill, PL; Thayer, B; Foreyt, JP
      Lifestyle treatments in randomized clinical trials of pharmacotherapies for obesity

      OBESITY RESEARCH
    2. Boschmann, M; Adams, F; Klaus, S
      In situ metabolic and hemodynamic response to dexfenfluramine in white adipose tissue of rats

      ANNALS OF NUTRITION AND METABOLISM
    3. Dickerson, VM
      Focus on primary care - Evaluation, management, and treatment of obesity in women

      OBSTETRICAL & GYNECOLOGICAL SURVEY
    4. Glazer, G
      Long-term pharmacotherapy of obesity 2000 - A review of efficacy and safety

      ARCHIVES OF INTERNAL MEDICINE
    5. Weissman, NJ
      Appetite suppressants and valvular heart disease

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    6. Mchelakis, ED; Weir, EK
      Anorectic drugs and pulmonary hypertension from the bedside to the bench

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    7. Mast, ST; Gersing, KR; Anstrom, KJ; Krishnan, KR; Califf, RM; Jollis, JG
      Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation

      AMERICAN JOURNAL OF CARDIOLOGY
    8. Ryan, DH
      Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity

      ENDOCRINE
    9. Proietto, J; Fam, BC; Ainslie, DA; Thorburn, AW
      Novel anti-obesity drugs

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    10. Rothberg, BEG; Ramesh, TM; Burgess, CE
      Integrating expression-based drug response and SNP-based pharmacogenetic strategies into a single comprehensive pharmacogenomics program

      DRUG DEVELOPMENT RESEARCH
    11. Ryan, DH
      Recent progress in obesity pharmacotherapy

      CURRENT OPINION IN GASTROENTEROLOGY
    12. Gardin, JM; Schumacher, D; Constantine, G; Davis, KD; Leung, C; Reid, CL
      Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    13. Jick, H
      Heart valve disorders and appetite-suppressant drugs

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    14. Roldan, CA; Gill, EA; Shively, BK
      Prevalence and diagnostic value of precordial murmurs for valvular regurgitation in obese patients treated with dexfenfluramine

      AMERICAN JOURNAL OF CARDIOLOGY
    15. Willison, DJ; MacLeod, SM
      The role of research evidence in pharmaceutical policy making: evidence when necessary but not necessarily evidence

      JOURNAL OF EVALUATION IN CLINICAL PRACTICE
    16. Pi-Sunyer, FX
      Heart valve lesions in patients treated with appetite suppressants

      OBESITY RESEARCH
    17. Mangion, JR; Habboub, AA; Kamat, BR; Tam, SKC
      Transesophageal echocardiography with pathological correlation in severe valvular disease associated with fenfluramine-phentermine

      ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
    18. Li, R; Serdula, MK; Williamson, DF; Bowman, BA; Graham, DJ; Green, L
      Dose-effect of fenfluramine use on the severity of valvular heart disease among fen-phen patients with valvulopathy

      INTERNATIONAL JOURNAL OF OBESITY
    19. Connolly, HM; McGoon, MD
      Obesity drugs and the heart

      CURRENT PROBLEMS IN CARDIOLOGY
    20. Kolanowski, J
      A risk-benefit assessment of anti-obesity drugs

      DRUG SAFETY
    21. Brewer, T; Colditz, GA
      Postmarketing surveillance and adverse drug reactions - Current perspectives and future needs

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    22. Wood, AJJ
      The safety of new medicines - The importance of asking the right questions

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    23. Asinger, RW
      The fen-phen controversy: Is regression another piece of the puzzle?

      MAYO CLINIC PROCEEDINGS
    24. Berg, FM
      Health risks associated with weight loss and obesity treatment programs

      JOURNAL OF SOCIAL ISSUES
    25. Carek, PJ; Dickerson, LM
      Current concepts in the pharmacological management of obesity

      DRUGS
    26. Fishman, AP
      Aminorex to fen/phen - An epidemic foretold

      CIRCULATION
    27. Shively, BK; Roldan, CA; Gill, EA; Najarian, T; Loar, SB
      Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine

      CIRCULATION
    28. Adams, C; Cohen, A
      Appetite-suppressant drugs and heart valve abnormalities.

      ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX
    29. CERULLI J; MALONE M
      OUTCOMES OF PHARMACOLOGICAL AND SURGICAL-TREATMENT FOR OBESITY

      PharmacoEconomics
    30. CERULLI J; LOMAESTRO BM; MALONE M
      UPDATE ON THE PHARMACOTHERAPY OF OBESITY

      The Annals of pharmacotherapy
    31. PERRI MG
      THE MAINTENANCE OF TREATMENT EFFECTS IN THE LONG-TERM MANAGEMENT OF OBESITY

      Clinical psychology (Cary)
    32. POSTON WSC; FOREYT JP; BORRELL L; HADDOCK CK
      CHALLENGES IN OBESITY MANAGEMENT

      Southern medical journal (Birmingham, Ala.)
    33. SHIFFMAN MA
      ANESTHESIA RISKS IN PATIENTS WHO HAVE HAD ANTIOBESITY MEDICATION

      Plastic and reconstructive surgery
    34. KHAN MA; HERZOG CA; STPETER JV; HARTLEY GG; MADLONKAY R; DICK CD; ASINGER RW; VESSEY JT
      THE PREVALENCE OF CARDIAC VALVULAR INSUFFICIENCY ASSESSED BY TRANSTHORACIC ECHOCARDIOGRAPHY IN OBESE PATIENTS TREATED WITH APPETITE-SUPPRESSANT DRUGS

      The New England journal of medicine
    35. JICK H; VASILAKIS C; WEINRAUCH LA; MEIER CR; JICK SS; DERBY LE
      A POPULATION-BASED STUDY OF APPETITE-SUPPRESSANT DRUGS AND THE RISK OF CARDIAC-VALVE REGURGITATION

      The New England journal of medicine
    36. HU SL; WANG SY; GIBSON J; GILBERTSON TA
      INHIBITION OF DELAYED RECTIFIER K+ CHANNELS BY DEXFENFLURAMINE (REDUX)

      The Journal of pharmacology and experimental therapeutics
    37. WEIR EK; REEVE HL; JOHNSON G; MICHELAKIS ED; NELSON DP; ARCHER SL
      A ROLE FOR POTASSIUM CHANNELS IN SMOOTH-MUSCLE CELLS AND PLATELETS INTHE ETIOLOGY OF PRIMARY PULMONARY-HYPERTENSION

      Chest
    38. RICH JM; NJO L; ROBERTS KW; SMITH KP
      UNUSUAL HYPOTENSION AND BRADYCARDIA IN A PATIENT RECEIVING FENFLURAMINE, PHENTERMINE, AND FLUOXETIME

      Anesthesiology
    39. LEW R; WEISENBERG B; VOSMER G; SEIDEN LS
      COMBINED PHENTERMINE FENFLURAMINE ADMINISTRATION ENHANCES DEPLETION OF SEROTONIN FROM CENTRAL TERMINAL FIELDS/

      Synapse
    40. DEMEO AT; MOBARHAN S; MIKOLAITIS S; KAZI N
      3 CASES OF COMPREHENSIVE DIETARY THERAPY AND PHARMACOTHERAPY OF PATIENTS WITH COMPLEX OBESITY-RELATED DISEASES

      Nutrition reviews
    41. BLACKBURN GL; MILLER D; CHAN S
      PHARMACEUTICAL TREATMENT OF OBESITY

      The Nursing clinics of North America
    42. DENKE MA
      WEIGHT-LOSS AS AN END-POINT - MEASURING THE EFFECTIVENESS OF TREATMENT IN OBESITY

      The Endocrinologist
    43. YANOVSKI SZ; DIETZ WH; GOODWIN NJ; HILL JO; PISUNYER FX; ROLLS B; STERN J; WEINSIER RL; WILSON GT; WING RR; HOOFNAGLE JH; EVERHART JE; HUBBARD VS
      LONG-TERM PHARMACOTHERAPY IN THE MANAGEMENT OF OBESITY

      JAMA, the journal of the American Medical Association
    44. ELKS ML
      APPETITE-SUPPRESSANTS AS ADJUNCTS IN THE TREATMENT OF OBESITY

      Journal of family practice

    45. TRACKING THE FENPHEN DRUG TREND

      Physician and sportsmedicine
    46. WILSON GT
      BEHAVIORAL TREATMENT OF OBESITY - 30 YEARS AND COUNTING

      Advances in behaviour research and therapy
    47. GOLDSTEIN DJ; POTVIN JH
      LONG-TERM WEIGHT-LOSS - THE EFFECT OF PHARMACOLOGICAL AGENTS

      The American journal of clinical nutrition
    48. ATKINSON RL; HUBBARD VS
      REPORT ON THE NIH WORKSHOP ON PHARMACOLOGICAL TREATMENT OF OBESITY

      The American journal of clinical nutrition


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/08/20 alle ore 19:12:34